Follow us on :

Cancer Reports and Reviews (CRR)

Online ISSN: 2513-9290

Dung-Fang Lee (Editor-in-Chief)

 The University of Texas

Cancer Reports and Reviews is a bimonthly, peer-reviewed journal provides cancer care professionals with up-to-date information on all aspects of cancer diagnosis, treatment, and prevention. The journal devoted to publication of original case reports and reviews in oncology.

CRR will feature original research, review papers, clinical studies, editorials, expert opinion and perspective papers, commentaries, and book reviews.

CRR welcomes direct submissions from authors: Attach your word file with e-mail and send it to alternatively to

Please, follow the Instructions for Authors. In the cover letter add the name and e-mail address of 5 proposed reviewers (we can choose them or not).

Copyright is retained by the authors and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by CRR, is properly cited.

Dung-Fang Lee

Dr. Lee received his Bachelor degree in Chemical Engineering and Master degree in Radiation Biology from National Tsing Hua University in Taiwan and PhD degree in Cancer Biology from the University Of Texas Graduate School Of Biomedical Sciences at Houston. In 2016 after completing the post-doctoral training in the Black Family Stem Cell Institute at Icahn School of Medicine at Mount Sinai, Dr. Lee joined the Department of Integrative Biology and Pharmacology, and the Center for Stem Cell and Regenerative Medicine at the University of Texas Health Science Center at Houston as an Assistant Professor. Dr. Lee is the first person applying iPSC disease model to study familial cancer syndrome. Currently, Dr. Lee is the CPRIT scholar in Cancer Research.

The Lee laboratory is dedicated to understand cancer pathological mechanisms by using patient-specific iPSCs and/or engineered ESCs. The Lee laboratory has established the first human Li-Fraumeni syndrome (LFS) disease model by using LFS patient-specific iPSCs to delineate the pathological mechanisms caused by mutant p53 in osteosarcoma. The Lee laboratory continues to apply TALENs and CRISPR/Cas9 genome editing tools to create variant p53 mutations in pluripotent stem cells (PSCs; e.g., iPSCs and ESCs) in order to explore the role of mutant p53 in osteosarcomagenesis. The Lee laboratory also works on modeling familial cancer syndromes with osteosarcoma predisposition by PSCs. Currently, the Lee laboratory applies whole genome sequencing, screening approaches and systems-level analyses to explore early genomic alterations and to understand dynamic alterations of the genomic landscape of LFS-associated osteosarcoma.

Dr. Lee’s research has been well recognized and published in journals as Cell, Cell Stem Cell, Molecular Cell, Cancer Cell, Cell Reports, Nature, Nature Cell Biology, Nature Protocols, Journal of Clinical Investigation, Trends in Cancer, and Trends in Biochemical Sciences.

Editorial Board

Dayson Friaca Moreira

Beckman Research Institute

Shouhao Zhou

Department of Biostatistics
Division of Quantitative Sciences
The University of Texas

Dr. Alireza Heidari

Faculty of Chemistry
California South University
Irvine, California

Vladimir Zaichick

Principal Investigator
Medical Radiological Research Centre

Ritesh Kumar

Assistant Professor
Radiation Oncology AIIMS, New Delhi

Sachin C. Sarode

Department of Oral Pathology and Microbiology
Dr. D.Y. Patil Dental College

Rajkumar K

Professor & Head Of the Department
SRM University

Chao-Kai Chou

Assistant Professor
Department of Molecular Oncology
UT MD Anderson Cancer Center

Francesca Aguilo

Assistant Professor. Wallenberg Centre for Molecular Medicine,
Department of Medical Biosciences, Umeå University,

Jian Chen

Assistant Professor
Department of Gastroenterology
Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas, USA

Xin Zhang

Principle Investigator
High Magnetic Field Laboratory
Chinese Academy of Sciences

Filipe Pereira

Group leader
Cell Reprograming and Developmental Hematopoiesis Laboratory
Center for Neuroscience and Cell Biology (CNC)
Universidade de Coimbra

Chia-Hsin (Lori) Chan

Assistant Professor
Department of Pharmacological Sciences
Stony Brook University
New York, USA

Zhao Ruiying

Assistant Professor
Department of Integrative Biology & Pharmacology
University of Texas McGovern Medical School

Junjun Ding

Zhongshan School of Medicine
Sun Yat-sen University
P.R. China

Early View

Volume 1, Issue 2

Social support, quality of life and mental health status in breast cancer patients

Jenesh Singh Shrestha Alish Shrestha Abja Sapkota Rakshya Sharma Samip Shrestha Sudip Shestha Kapendra Sekhar Amayta Madhav Gautam

Research Article-Clinical Research and Trials (CRT)

February 01, 2017

Immunotherapy and small cell lung cancer (SCLC)

Timothy Allen Nepton Sheikh-Khoni Naveed Basha Court

Research Article-Cancer Reports and Reviews (CRR)

February 04, 2017

Immunotherapy and squamous cell carcinoma

Timothy Allen Nepton Sheikh-Khoni Naveed Basha Court

Research Article-Cancer Reports and Reviews (CRR)

February 04, 2017

Immunotherapy and urinary bladder cancer

Timothy Allen Nepton Sheikh-Khoni Naveed Basha Court

Short Communication-Cancer Reports and Reviews (CRR)

February 07, 2017

The histogenesis of Ewing Sarcoma

Jian Tu Zijun Huo Julian Gingold Ruiying Zhao Jingnan Shen Dung-Fang Lee

Short Communication-Cancer Reports and Reviews (CRR)

February 07, 2017

Propolis gel versus benzydamine in preventing oral mucositis for patients irradiated in head and neck: a preliminary study

Noronha VRAS Abdo EN Persio FPCL SantosVR

Research Article-Cancer Reports and Reviews (CRR)

February 17, 2017

Randomized clinical study of SCP pacliataxel in patients with advanced cervical cancer

Timothy Allen Nepton Sheik Khoni Bruce Dunphy Naveed Basha Court

Research Article-Cancer Reports and Reviews (CRR)

February 18, 2017

Extremely high serum level of carbohydrate antigen 19-9 in a patient with colon adenocarcinoma

Jing Deng Qi Shi Wasique Mirza Mladen Jecmenica Michael Yoder Rajan Mulloth Erin Gordon Arpit Sothwal Sowmya Thanneeru Sirish Dharmapuri

Research Article-Cancer Reports and Reviews (CRR)

March 10, 2017

Current Issue

Volume 1, Issue 1

Hypoxia induces therapeutic resistance and enhances subsequent reformulated tumorigenesis and metastasis

Lawrence M. Agius

Case Report-Cancer Reports and Reviews (CRR)

December 23, 2016

A rare case of subungual exostosis of the hallux in an adolescent-a clinico-pathological review of literature

Supreeth Nekkanti Arunodhaya Siddartha Sujana Theja Vijay C and Abhilash Gowd

Case Report-Cancer Reports and Reviews (CRR)

December 27, 2016

A man patient with ipsilateral breast metastasis from pulmonary adenocarcinoma

Ayperi Ozturk Derya Yenibertiz Zafer Aktas Aydın Yılmaz Funda Demirag

Case Report-Cancer Reports and Reviews (CRR)

January 03, 2017

Symptoms based cancer diagnosis–An inconceivable strategy

Williams Fernandes Barra Taíssa Maíra Thomaz Araújo Danielle Queiroz Calcagno André Salim Khayat Sidney Emanuel Batista dos Santos Ney Pereira Carneiro dos Santos Carolina Baraúna Assumpção Aline Maria Pereira Cruz Geraldo Ishak Ândrea Kely Campos Ribeiro-dos-Santos Rommel Mario Rodriguez Burbano Gregory Joseph Riggins Paulo Pimentel de Assumpção

Review Article-Cancer Reports and Reviews (CRR)

January 20, 2017

Ratios of Zn/trace element contents in prostate gland as carcinoma’s markers

Vladimir Zaichick Sofia Zaichick

Research Article-Cancer Reports and Reviews (CRR)

January 23, 2017

A case study of rare lympho-epithelioma like esophageal carcinoma

Abhishek Mukherjee Jaydeep Nath Srimanti Sinha Tridip Chatterjee

Case Report-Cancer Reports and Reviews (CRR)

January 27, 2017

Previous Issue

Will be updated soon.


Will be updated soon.

Submit Manuscript

CRR welcomes direct submissions from authors: Attach your word file with e-mail and send it to alternatively to

Publication Charges